LATEST
EQT agreed to acquire CleanawayNavigator Gas / Navigator HoldingsAlcoa / AliGroupInternational Seaways agreed to acquire BrutonBoston Crest PVT / LQR HouseBrady acquired Productivity Solutions and Services businessJMSB / EFSIVista Equity Partners / PKI Business UnitBluegem Capital Partners / Rispo GroupApax Partners agreed to acquire OdidoGTCR agreed to acquire CCC Intelligent SolutionsEQT agreed to acquire Stockbridge
Open App
ClosedPublished 15 Apr 2025

OS Therapies /
Ayala Pharmaceuticals

OS Therapies completes immunotherapy asset acquisition

Buy side: OS Therapies
Buy sideOS Therapies
Target: Ayala Pharmaceuticals
TargetAyala Pharmaceuticals
Source · 15 Apr 2025Source-verified
See the source
Buy side: OS Therapies
Buy sideOS Therapies
Target: Ayala Pharmaceuticals
TargetAyala Pharmaceuticals
01 / BuyerOS Therapies
02 / TargetAyala Pharmaceuticals
Source-verified
01

What happened

OS Therapies completed its acquisition of listeria-based cancer immunotherapy assets from Ayala Pharmaceuticals. The transaction involved an aggregate purchase price of $8,000,000, paid in cash, to a third party on Ayala’s behalf, and in OS Therapies common stock.

02

The source

Everything on this page comes from the source below.

01
Source · Original source

OS Therapies completes immunotherapy asset acquisition

This document is the source for the companies, stage and people on this page.

Source-verified
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

    Source-verified

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request an inviteAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.